Forwardly’s Ligand Innovation Global Makes Significant Strides Towards FDA Submission
04. August 2021 10:00 ET
|
Forwardly, Inc.
Mississauga, ON and Henderson, NV, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Dr. Dayo Olakulehin, CEO of Ligand Innovation Global, Inc., (“Ligand”) a partially owned company and partner of Forwardly, Inc....